Additionally, elevated VEGF may contribute to more aggressive HCC characteristics, such as infiltrative or metastatic transformations, and the formation of collateral tumor blood supplies, which can lead to resistance against TACE treatment [34]. This evidence concerns the gene VEGFA and neoplasm.